A Novel Prognostic Scoring Model Based on Albumin and Γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s232073
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Scoring System for Metastatic Spine Tumors Derived From Hepatocellular Carcinoma

Journal of Orthopaedic Surgery
Surgery
2020English

A Novel microRNAs Expression Signature for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

Development and Validation of a Novel Immune-Related Prognostic Model in Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Reply: A Morpho-Molecular Prognostic Model for Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2013English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients With Hepatocellular Carcinoma Underwent Hepatectomy

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Prognostic Value of Γ-Glutamyltransferase-To-Albumin Ratio in Patients With Pancreatic Ductal Adenocarcinoma Following Radical Surgery

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy